drugset
drugset / Trial / NCT03781375

Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

NCT03781375 ↗

Phase 3 Terminated 25 enrolled Amgen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study was to determine the efficacy of etanercept plus methotrexate vs methotrexate alone in pediatric patients with active polyarticular course juvenile rheumatoid arthritis (JRA).

Timeline

Start
2000-08-24
Primary completion
2002-06-20
Completion
2002-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 0.4 mg/kg Subcutaneous
Background Methotrexate Small molecule — Oral

Indications

polyarticular juvenile rheumatoid arthritis